- Report
- November 2026
- 204 Pages
Global
From €5377EUR$5,850USD£4,488GBP
- Report
- November 2026
- 373 Pages
Global
From €5377EUR$5,850USD£4,488GBP
- Report
- November 2026
- 384 Pages
Global
From €5377EUR$5,850USD£4,488GBP
- Report
- November 2026
- 235 Pages
Global
From €5377EUR$5,850USD£4,488GBP
- Report
- November 2026
- 174 Pages
Global
From €5377EUR$5,850USD£4,488GBP
- Report
- July 2026
- 200 Pages
Global
From €7343EUR$7,990USD£6,130GBP
- Report
- July 2026
- 200 Pages
Global
From €7343EUR$7,990USD£6,130GBP
- Report
- July 2026
- 160 Pages
Global
From €3051EUR$3,320USD£2,547GBP
€3814EUR$4,150USD£3,184GBP
- Report
- December 2025
- 142 Pages
Global
From €4457EUR$4,850USD£3,721GBP
- Report
- September 2026
- 101 Pages
Global
From €3500EUR$4,079USD£3,024GBP
- Report
- September 2026
- 139 Pages
Global
From €3500EUR$4,079USD£3,024GBP
- Report
- September 2026
- 200 Pages
Saudi Arabia
From €2288EUR$2,490USD£1,910GBP
- Report
- September 2023
- 180 Pages
Global
From €5468EUR$5,950USD£4,565GBP
- Report
- May 2025
- 100 Pages
Global
From €4503EUR$4,900USD£3,759GBP
- Report
- June 2025
- 138 Pages
Global
From €3675EUR$3,999USD£3,068GBP
- Report
- May 2024
- 135 Pages
Global
From €3675EUR$3,999USD£3,068GBP
- Report
- May 2024
- 132 Pages
Global
From €3675EUR$3,999USD£3,068GBP
- Report
- May 2025
- 120 Pages
Global
From €5468EUR$5,950USD£4,565GBP
- Report
- August 2024
- 220 Pages
Global
From €5468EUR$5,950USD£4,565GBP
- Report
- July 2024
- 130 Pages
Global
From €5468EUR$5,950USD£4,565GBP

Retinal Vein Occlusion (RVO) is a condition in which the veins in the retina become blocked, leading to vision loss. It is the second most common cause of vision loss in the elderly, and is often caused by hypertension, diabetes, and other vascular diseases. Treatment for RVO includes laser photocoagulation, intravitreal injections, and vitrectomy. Optical treatments such as optical coherence tomography (OCT) and fundus photography are used to diagnose and monitor the condition.
In the RVO market, companies such as Carl Zeiss Meditec, Topcon Corporation, Heidelberg Engineering, Optovue, and Nidek Co. Ltd. are involved in the development and manufacture of optical imaging systems and treatments for RVO. These companies provide a range of products and services, including OCT systems, fundus cameras, laser photocoagulation systems, and intravitreal injections. Show Less Read more